Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Lags Revenue Estimates

• click to rate

  Posted by Two Blokes May 12 - Filed in Stock - 2 views
  
  Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.35 per share a year ago.